New treatment strategy for Smith-Lemli-Opitz syndrome

Lancet. 1997 Apr 26;349(9060):1222. doi: 10.1016/S0140-6736(05)62415-4.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Anticholesteremic Agents / therapeutic use*
  • Dehydrocholesterols / blood
  • Enzyme Inhibitors / therapeutic use
  • Exchange Transfusion, Whole Blood*
  • Female
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Infant
  • Lovastatin / analogs & derivatives*
  • Lovastatin / therapeutic use
  • Simvastatin
  • Smith-Lemli-Opitz Syndrome / drug therapy
  • Smith-Lemli-Opitz Syndrome / therapy*

Substances

  • Anticholesteremic Agents
  • Dehydrocholesterols
  • Enzyme Inhibitors
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Lovastatin
  • Simvastatin
  • 7-dehydrocholesterol